Details for New Drug Application (NDA): 088682
✉ Email this page to a colleague
NDA 088682 describes DEXCHLORPHENIRAMINE MALEATE, which is a drug marketed by Pai Holdings Pharm and Ani Pharms and is included in two NDAs. Additional details are available on the DEXCHLORPHENIRAMINE MALEATE profile page.
The generic ingredient in DEXCHLORPHENIRAMINE MALEATE is dexchlorpheniramine maleate. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the dexchlorpheniramine maleate profile page.
The generic ingredient in DEXCHLORPHENIRAMINE MALEATE is dexchlorpheniramine maleate. There are six drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the dexchlorpheniramine maleate profile page.
Summary for 088682
| Tradename: | DEXCHLORPHENIRAMINE MALEATE |
| Applicant: | Ani Pharms |
| Ingredient: | dexchlorpheniramine maleate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 2MG | ||||
| Approval Date: | Jan 17, 1986 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
